<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen X</submitter><funding>the Program for Changjiang Scholars and Innovative Research Team in University</funding><funding>the Scientific Research Innovation Project in Shihezi University</funding><funding>the Xinjiang Science and Technology Major Project</funding><pagination>E2950</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6720801</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(16)</volume><pubmed_abstract>Utilizing a pharmacophore hybridization approach, we have designed and synthesized a novel series of 28 new heterobivalent β-carbolines. The in vitro cytotoxic potential of each compound was evaluated against the five cancer cell lines (LLC, BGC-823, CT-26, Bel-7402, and MCF-7) of different origin-murine and human, with the aim of determining the potency and selectivity of the compounds. Compound &lt;b>8z&lt;/b> showed antitumor activities with half-maximal inhibitory concentration (IC&lt;sub>50&lt;/sub>) values of 9.9 ± 0.9, 8.6 ± 1.4, 6.2 ± 2.5, 9.9 ± 0.5, and 5.7 ± 1.2 µM against the tested five cancer cell lines. Moreover, the effect of compound &lt;b>8z&lt;/b> on the angiogenesis process was investigated using a chicken chorioallantoic membrane (CAM) in vivo model. At a concentration of 5 μM, compound </pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Design, Synthesis, and Biological Evaluation of Novel N-Acylhydrazone Bond Linked Heterobivalent β-Carbolines as Potential Anticancer Agents.</pubmed_title><pmcid>PMC6720801</pmcid><funding_grant_id>IRT15R46</funding_grant_id><funding_grant_id>2016A03005-1</funding_grant_id><funding_grant_id>SHYL-YB201804</funding_grant_id><pubmed_authors>Ma Q</pubmed_authors><pubmed_authors>Guo L</pubmed_authors><pubmed_authors>Fan W</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Chen X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design, Synthesis, and Biological Evaluation of Novel N-Acylhydrazone Bond Linked Heterobivalent β-Carbolines as Potential Anticancer Agents.</name><description>Utilizing a pharmacophore hybridization approach, we have designed and synthesized a novel series of 28 new heterobivalent β-carbolines. The in vitro cytotoxic potential of each compound was evaluated against the five cancer cell lines (LLC, BGC-823, CT-26, Bel-7402, and MCF-7) of different origin-murine and human, with the aim of determining the potency and selectivity of the compounds. Compound &lt;b>8z&lt;/b> showed antitumor activities with half-maximal inhibitory concentration (IC&lt;sub>50&lt;/sub>) values of 9.9 ± 0.9, 8.6 ± 1.4, 6.2 ± 2.5, 9.9 ± 0.5, and 5.7 ± 1.2 µM against the tested five cancer cell lines. Moreover, the effect of compound &lt;b>8z&lt;/b> on the angiogenesis process was investigated using a chicken chorioallantoic membrane (CAM) in vivo model. At a concentration of 5 μM, compound </description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Aug</publication><modification>2026-05-06T21:32:39.752Z</modification><creation>2019-09-14T07:04:45Z</creation></dates><accession>S-EPMC6720801</accession><cross_references><pubmed>31416271</pubmed><doi>10.3390/molecules24162950</doi></cross_references></HashMap>